VJVictor Nunes de Jesus

Victor Nunes de Jesus

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victor Nunes de Jesus has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterization of Five Purine Riboswitches in Cellular and Cell-Free Expression Systems

    by Milca Rachel da Costa Ribeiro Lins, Graciely Gomes Corrêa, Laura Araujo da Silva Amorim, Rafael Augusto Lopes Franco, Nathan Vinicius Ribeiro, Victor Nunes de Jesus, Danielle Biscaro Pedrolli

    Bacillus subtilis employs five purine riboswitches for the control of purine de novo synthesis and transport at the transcription level. All of them are formed by a structurally conserved aptamer, and a variable expression platform harboring a rho-independent transcription terminator. In this study, we characterized all five purine riboswitches under the context of active gene expression processes both in vitro and in vivo. We identified transcription pause sites located in the expression platform upstream of the terminator of each riboswitch. Moreover, we defined a correlation between in vitro transcription readthrough and in vivo gene expression. Our in vitro assay demonstrated that the riboswitches operate in the micromolar range of concentration for the cognate metabolite. Our in vivo assay showed the dynamics of the control of gene expression by each riboswitch. This study deepens the knowledge of the regulatory mechanism of purine riboswitches.


  • The CRISPR toolbox for the gram-positive model bacterium Bacillus subtilis

    by Vitoria Fernanda Bertolazzi Zocca, Graciely Gomes Corrêa, Milca Rachel da Costa Ribeiro Lins, Victor Nunes de Jesus, Leonardo Ferro Tavares, Laura Araujo da Silva Amorim, Guilherme Engelberto Kundlatsch, Danielle Biscaro Pedrolli

    CRISPR has revolutionized the way we engineer genomes. Its simplicity and modularity have enabled the development of a great number of tools to edit genomes and to control gene expression. This powerful technology was first adapted to Bacillus subtilis in 2016 and has been intensely upgraded since then. Many tools have been successfully developed to build a CRISPR toolbox for this Gram-positive model and important industrial chassis. The toolbox includes tools, such as double-strand and single-strand cutting CRISPR for point mutation, gene insertion, and gene deletion up to 38 kb. Moreover, catalytic dead Cas proteins have been used for base editing, as well as for the control of gene expression (CRISPRi and CRISPRa). Many of these tools have been used for multiplex CRISPR with the most successful one targeting up to six loci simultaneously for point mutation. However, tools for efficient multiplex CRISPR for other functionalities are still missing in the toolbox. CRISPR engineering has already resulted in efficient protein and metabolite-producing strains, demonstrating its great potential. In this review, we cover all the important additions made to the B. subtilis CRISPR toolbox since 2016, and strain developments fomented by the technology. Graphical abstract